Detection of tetrahydroisoquinoline in parkinsonian brain as an endogenous amine by use of gas chromatography-mass spectrometry. 1989

T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
Department of Internal Medicine, Nagoya University Branch Hospital, Japan.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014297 Trimethylsilyl Compounds Organic silicon derivatives used to characterize hydroxysteroids, nucleosides, and related compounds. Trimethylsilyl esters of amino acids are used in peptide synthesis. Compounds, Trimethylsilyl
D044005 Tetrahydroisoquinolines A group of ISOQUINOLINES in which the nitrogen containing ring is protonated. They derive from the non-enzymatic Pictet-Spengler condensation of CATECHOLAMINES with ALDEHYDES. Tetrahydro-Isoquinoline,1,2,3,4-Tetrahydroisoquinolines,Tetrahydro-Isoquinolines,Tetrahydro Isoquinoline,Tetrahydro Isoquinolines

Related Publications

T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
December 1999, Journal of chromatography. B, Biomedical sciences and applications,
T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
July 1995, Journal of chromatography. B, Biomedical applications,
T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
May 1993, Journal of chromatography,
T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
April 1984, Biomedical mass spectrometry,
T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
December 1995, Journal of neurochemistry,
T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
December 1978, The Journal of pharmacy and pharmacology,
T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
December 2002, Clinical chemistry,
T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
January 1974, Life sciences,
T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
May 1999, Journal of chromatography. A,
T Niwa, and N Takeda, and T Sasaoka, and N Kaneda, and Y Hashizume, and H Yoshizumi, and A Tatematsu, and T Nagatsu
May 1975, Soudni lekarstvi,
Copied contents to your clipboard!